Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

Citations Over Time

Abstract

Summary We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics. To date we have identified thirteen mutations in Spike that are accumulating. Mutations are considered in a broader phylogenetic context, geographically, and over time, to provide an early warning system to reveal mutations that may confer selective advantages in transmission or resistance to interventions. Each one is evaluated for evidence of positive selection, and the implications of the mutation are explored through structural modeling. The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February, and when introduced to new regions it rapidly becomes the dominant form. Also, we present evidence of recombination between locally circulating strains, indicative of multiple strain infections. These finding have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions.

Related Papers

• → Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P.3 Variant(2021)11 cited
• → Author response for "Conformational variability of loops in the SARS‐CoV ‐2 spike protein"(2021)
• → Review for "Conformational variability of loops in the SARS‐CoV ‐2 spike protein"(2021)
• → Faculty Opinions recommendation of Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses.(2023)
• → Retraction Note: Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome.(2024)